Import of Patent Medicine Grew by 14.5% in Monetary Terms
According to RNC Pharma, Russia imported patent medicine at a total cost of RUB 336.3 billion (market prices, including VAT) over the seven months of this year. This is 14.5% more than in the same period last year.
In monetary terms, the supply of unprepacked drugs reached RUB 65.6 billion during this period, which is 4.5% more than last year. The natural volumes of imported patent medicine in these seven months have decreased by 2.1% (1.03 billion packages in total).
In July, the total import of patent medicine to our country in roubles was 61.5 billion, which is the largest monthly figure since August 2010. The long-term increase in roubles (compared with July of last year) was also significant – 31.5% in total.